Ovarian Cancer Research Alliance (@ocrahope) header
Ovarian Cancer Research Alliance (@ocrahope) profile picture

OCRA is the largest non-profit organization in the world combating ovarian and all gynecologic cancers.

DC and NYC
Joined January 2016
Photo by Ovarian Cancer Research Alliance (@ocrahope)Photo by Ovarian Cancer Research Alliance (@ocrahope)Photo by Ovarian Cancer Research Alliance (@ocrahope)Photo by Ovarian Cancer Research Alliance (@ocrahope)Photo by Ovarian Cancer Research Alliance (@ocrahope)Photo by Ovarian Cancer Research Alliance (@ocrahope)Photo by Ovarian Cancer Research Alliance (@ocrahope)Photo by Ovarian Cancer Research Alliance (@ocrahope)Photo by Ovarian Cancer Research Alliance (@ocrahope)Photo by Ovarian Cancer Research Alliance (@ocrahope)
Thanks to the generosity of all who give to OCRA, we can continue to offer support, advance research, and advocate for our community. Visit bit.ly/4f02Gda to learn about the many ways to donate, such as giving through stocks or IRAs.
1
1
59
Clear, current information is a crucial resource when navigating a diagnosis. An updated guide about ovarian cancer offered by the National Comprehensive Cancer Network (@NCCN) & proudly sponsored by OCRA is now available: bit.ly/4kkueNV
1
73
OCRA welcomed the opportunity to connect with attendees at the Race to End Women’s Cancer last month in Washington, DC, where we raised awareness about ovarian & gynecologic cancers. Thank you to our volunteers, all who stopped by our table, and the Foundation for Women’s Cancer for bringing so many of us together in support of our shared cause. @GYNCancer @ChemoBabe1
78
OCRA is thrilled to have brought together more than 375 ovarian cancer researchers, clinicians, and advocates to share findings at the 16th Biennial Rivkin Ovarian Cancer Research Symposium in Philadelphia: bit.ly/48dNKo3. Sessions explored a wide range of topics, including immuno-oncology, prevention and early detection, and rare subtypes. Thank you to all who attended! OCRA is grateful to the sponsors who made the Symposium possible, including Presenting Scientific Sponsor @AbbVie; Advocate Sponsors @AstraZeneca, Corcept Therapeutics, and @Genmab; and Contributor Sponsor @GSK. @Ronny_Drapkin @SophiaHLGe @GillianEHanley
1
8
159
Research advances are changing how biomarker tests are used to personalize gynecologic cancer care. Sarah Ackroyd, MD, MPH, of @UChicago, will discuss biomarkers and their role in treatment during OCRA’s free webinar on Oct. 28. Register: bit.ly/4Bp9SJt @SarahAckroydMD @UChicagoMed @UCCancerCenter
4
4
217
More than 700 people have joined the Living Lab. What does that actually mean for research? Living Lab Principal Investigator Leigh Pearce explains what’s already possible and what becomes possible as the registry grows: bit.ly/4dUlNoG
3
131
Have you or a loved one been diagnosed with FATWO (female adnexal tumor of Wolffian origin)? Connect with others who share this rare diagnosis during a special online meetup on Oct. 22 at 12:30 pm ET. For more information and the meeting link, contact [email protected]
92
Get details about an early study showing that a blood test combining platelet RNA with routine blood-count data detected ovarian cancer more accurately than CA-125; an analysis involving 91,000 patients demonstrating that robotic and laparoscopic hysterectomy provide similar survival outcomes for endometrial cancer; and other findings. Learn more at bit.ly/480cjVp
2
2
108
Join OCRA for an interactive online roundtable offering a supportive space for patients & survivors who have faced both a breast and gynecologic cancer diagnosis. Register: bit.ly/4zDqI5F
1
73
Cancer-fighting T cells mass-produced from blood stem cells and engineered to target a protein known as NY-ESO-1 show promise for treating ovarian cancer and other solid tumors. Developed by UCLA researchers, this method may offer an alternative to the costly and lengthy process currently used, which requires each patient’s own T cells. @DGSoMUCLA @MicrobioUCLA @UCLAHealthJCCC uclahealth.org/news/release/…
1
2
124
Leaders in ovarian cancer research and treatment are coming together in Philadelphia for the 16th Biennial Rivkin Ovarian Cancer Research Symposium, now presented by OCRA. As we get ready to delve into the latest discoveries in the field, OCRA wants to take a moment to acknowledge the following sponsors for their support of the Symposium: Presenting Scientific Sponsor @AbbVie; Advocate Sponsors @AstraZeneca, Corcept Therapeutics, and @Genmab; and Contributor Sponsor @GSK. Thank you!
1
2
120
Our final answer is… gratitude! Thank you, Jackie Tohn, for donating your winnings from “Who Wants To Be A Millionaire” to OCRA. And many congrats on a game well played alongside your teammate and “Nobody Wants This” co-star Timothy Simons: bit.ly/3U1Rh5n. @JackieTohn @TimothyCSimons @JimmyKimmel @MillionaireTV @ABCNetwork @Hulu @Disney @NWTNetflix #WhoWantsToBeAMillionaire
1
142
Having a basic understanding of ovarian cancer care can help patients and loved ones feel better informed and more empowered to ask questions when faced with treatment decisions. OCRA is offering a free online workshop covering the standard of care, types and side effects of common treatments, and more. Register: bit.ly/4yZL0X2
1
99
Navigating a dual diagnosis of breast and gynecologic cancer can bring a complex set of emotions, questions, and decisions. OCRA is offering a free interactive roundtable for patients & survivors to connect: bit.ly/4hYZD60
1
101
Don’t miss this opportunity to join leading ovarian cancer researchers to learn about the latest breakthroughs and exchange ideas at the 16th Biennial Rivkin Ovarian Cancer Research Symposium in Philadelphia, Oct. 16-18, 2026. Topics will include novel therapeutics, immuno-oncology, rare tumors, and more. Register at bit.ly/4jR5DQC #OvarianCancerResearch #OvarianSymposium
1
102
OCRA will host a fall-themed art activity & discussion for gyn cancer patients & survivors on Oct. 29. Art supplies provided at no cost for this free online session. Register: bit.ly/4dYxiLK
1
100
OncoDaily highlights OCRA Pres. & CEO Audra Moran’s insights into how OCRA’s Center for Public Policy led the efforts to bring forward the Ovarian Cancer IMPACT Act: bit.ly/3VVqjwU. This bipartisan legislation is designed to expand access to genetic testing and specialized gynecologic cancer care, as well as strengthen education about hereditary cancer risk and risk-reduction strategies. @OncoDaily @SenatorSlotkin @SenKatieBritt @RosaDeLauro @RepDonBacon @Cramz32 #TealAction #GynCSM
3
9
223
OCRA’s Pres. & CEO Audra Moran spoke about the power of the patient voice in the future of AI and research at today’s AWS Women in AI Forum, which brought together leaders in healthcare and life sciences. Pictured left to right: Dawn Heisey-Grove, PhD, Global Health Lead, Skilling and Social Impact, Amazon Web Services (AWS); Nina Akerley Lindsey, Chief Marketing Officer, GE Healthcare; Anish Sebastian, CEO & Co-Founder, Babyscripts; Audra Moran, Pres. & CEO, Ovarian Cancer Research Alliance @ASebastian87 @AWScloud @AWSnewsroom @Babyscripts @GEHealthCare #AWS #HealthTech
3
132